GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

navepegritide   Click here for help

GtoPdb Ligand ID: 14293

Synonyms: TransCon CNP
Compound class: Peptide
Comment: Navepegritide (TransCon CNP) is a prodrug of a human C-type natriuretic peptide (CNP) analogue [1]. It comprises CNP(1-38) attached to an inert polyethylene glycol carrier via a cleavable linker [3]. CNP is a validated therapeutic agent for the treatment of patients with achondroplasia (see the approved CNP analogue vosoritide) [2]. Navepegritide is designed to provide sustained hormone release and continuous CNP exposure as a once-weekly therapy that is proposed to counterbalance the overactivated FGFR3 signaling pathway in achondroplasia [1].

For advanced searching click here to open chemical structure editor

Other Similar Sequences Click here for help
[125I]CNP (human)
Targets
Guanylyl cyclase-B
[Ser11](N-CNP,C-ANP)pBNP2-15
Targets
Guanylyl cyclase-B
C-type natriuretic peptide  {Sp: Human}
Targets
Guanylyl cyclase-A; Guanylyl cyclase-B; natriuretic peptide receptor 3
vosoritide
Targets
Guanylyl cyclase-B
peptide P19 [PMID: 15652659]
Targets
Guanylyl cyclase-B